共 50 条
- [21] Neoadjuvant eribulin plus carboplatin vs. paclitaxel plus carboplatin in patients with triple-negative breast cancer (TNBC)ANNALS OF ONCOLOGY, 2018, 29Gigolaeva, L.Krivorotko, P.Khadzhimatova, S.Zhiltsova, E.Yerechshenko, S.Nikitina, M.Ni, V.Emelyanov, A.Imyanitov, E. N.Sokolenko, A. P.Tabagua, T.
- [22] Pathologic response to neoadjuvant therapy with nabpaclitaxel plus carboplatin followed by anthracycline regimen in triple-negative breast cancer.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)David Cardenas, JuanEsteban, CarmenGarcia Carbonero, IciarRosero, AdrianaMartinez Barroso, KatherinBorrecion Rivilla, MiguelRubio Salvador, Ana RosaAguilar Anqulo, Paul MartinGarcia Avila, MariaIgnacio Chacon, JoseRuiz Martin, Juan
- [23] Camrelizumab in Combination with Nab-Paclitaxel and Carboplatin versus Nab-Paclitaxel and Carboplatin as Neoadjuvant Therapy for Triple Negative Breast Cancer: A Multicenter, Open-Label, Randomized Controlled StudyCANCER RESEARCH, 2024, 84 (09)Zhao, WeipengWang, XinZhang, BinShi, YehuiWang, ChenWang, XuLi, ShufenHao, ChunfangLu, NingJia, YongshengZhang, LiZhang, LanSun, WeixinCao, XuchenTong, Zhongsheng
- [24] Evaluation of weekly paclitaxel plus carboplatin followed by anthracycline chemotherapy on the neoadjuvant treatment of patients with triple-negative breast cancerCANCER RESEARCH, 2017, 77Castrellon, A. B.Velez, M.Blaya, M.Barnick, S.Dumais, K.LeCroy, N.
- [25] Strong and Sustained Response to Treatment with Carboplatin plus Nab-Paclitaxel in a Patient with Metastatic, Triple-Negative, BRCA1-Positive Breast CancerCASE REPORTS IN ONCOLOGY, 2014, 7 (01): : 252 - 259Shakir, Abdur R.
- [26] Neoadjuvant anthracycline followed by toripalimab combined with nab-paclitaxel in patients with early triple-negative breast cancer (NeoTENNIS): a single-arm, phase II studyECLINICALMEDICINE, 2024, 74He, MinHao, ShuangMa, LinXiaoxiXiu, BingQiuYang, BenLongWang, ZeHaoXue, JingYanChi, YaYunXiong, MinChen, JiajianHuang, XiaoYanLiu, XiYuWu, SongYangXiao, QinHuang, YanShui, RuoHongCao, AYongLi, JunJieDi, GenHongYang, WenTaoHu, XinLiu, GuangYuYu, KeDaJiang, YiZhouWang, ZhongHuaShao, ZhiMingWu, Jiong
- [27] Neoadjuvant, anthracycline-free chemotherapy with carboplatin and docetaxel in triple-negative, early-stage breast cancer: a multicentric analysis of rates of pathologic complete response and survivalJOURNAL OF CHEMOTHERAPY, 2016, 28 (03) : 210 - 217Kern, PeterKalisch, Annevon Minckwitz, GunterPuetter, CarolinKolberg, Hans-ChristianPott, DirkKurbacher, ChristianRezai, MahdiKimmig, Rainer
- [28] Neoadjuvant, Anthracycline-Free Chemotherapy with Carboplatin and Docetaxel in Triple-Negative, Early-Stage Breast Cancer: A Multicentric Analysis of Feasibility and Rates of Pathologic Complete ResponseCHEMOTHERAPY, 2013, 59 (05) : 387 - 394Kern, PeterKalisch, AnneKolberg, Hans-ChristianKimmig, RainerOtterbach, Friederichvon Minckwitz, GunterSikov, William M.Pott, DirkKurbacher, Christian
- [29] Pathologic complete response rates observed in women with locally advanced and inflammatory breast cancer receiving neoadjuvant carboplatin and paclitaxelJOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)Shinde, Arvind ManoharYim, John H.Kruper, LauraVito, CourtneyChen, Steven L.Paz, Isaac BenjaminLuu, Thehang H.Tagawa, TomokoYu, Kim WaiWilczynski, SharonShaw, SallyVora, LalitPark, Jinha MarkSomlo, George
- [30] Pilot study of carboplatin, nab-paclitaxel and pembrolizumab for metastatic triple-negative breast cancer (ongoing clinical trial)CANCER RESEARCH, 2017, 77Baar, J.Abraham, J.Silverman, P.Budd, G. T.Vinayak, S.Varadan, V.Moore, H.Montero, A.Fu, P.